Innova Captab Ltd
Incorporated in January 2005, Innova Captab Ltd is a pharmaceutical company is an integrated pharmaceutical company in India with a presence across the pharmaceutical value chain.[1]
- Market Cap ₹ 4,988 Cr.
- Current Price ₹ 872
- High / Low ₹ 1,260 / 421
- Stock P/E 55.8
- Book Value ₹ 142
- Dividend Yield 0.00 %
- ROCE 11.6 %
- ROE 11.6 %
- Face Value ₹ 10.0
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Part of BSE Healthcare BSE SmallCap BSE Allcap Nifty Microcap 250 Nifty Total Market
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
373 | 411 | 785 | 859 | 865 | 958 | |
322 | 356 | 687 | 760 | 755 | 836 | |
Operating Profit | 51 | 54 | 99 | 99 | 110 | 122 |
OPM % | 14% | 13% | 13% | 11% | 13% | 13% |
1 | 1 | 3 | 9 | 9 | 17 | |
Interest | 5 | 4 | 5 | 18 | 14 | 2 |
Depreciation | 10 | 6 | 7 | 11 | 11 | 17 |
Profit before tax | 38 | 46 | 89 | 78 | 94 | 120 |
Tax % | 26% | 26% | 25% | 26% | 27% | 25% |
28 | 34 | 66 | 58 | 68 | 89 | |
EPS in Rs | 232.42 | 287.50 | 551.50 | 11.99 | 11.91 | 15.63 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 21% |
3 Years: | 7% |
TTM: | 11% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 26% |
3 Years: | 11% |
TTM: | 29% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 80% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 17% |
3 Years: | 14% |
Last Year: | 12% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Equity Capital | 12 | 12 | 12 | 48 | 57 | 57 |
Reserves | 98 | 133 | 199 | 220 | 666 | 756 |
54 | 45 | 176 | 237 | 244 | 329 | |
81 | 178 | 157 | 173 | 187 | 223 | |
Total Liabilities | 245 | 368 | 544 | 678 | 1,155 | 1,365 |
73 | 79 | 161 | 161 | 164 | 637 | |
CWIP | 0 | 7 | 0 | 22 | 339 | 21 |
Investments | 0 | 0 | 60 | 60 | 60 | 60 |
172 | 282 | 322 | 435 | 593 | 647 | |
Total Assets | 245 | 368 | 544 | 678 | 1,155 | 1,365 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
31 | 42 | 58 | 39 | 112 | 20 | |
-6 | -20 | -188 | -88 | -472 | -100 | |
-23 | -19 | 125 | 51 | 368 | 84 | |
Net Cash Flow | 1 | 3 | -5 | 3 | 8 | 4 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Debtor Days | 85 | 123 | 81 | 98 | 92 | 95 |
Inventory Days | 84 | 107 | 63 | 67 | 68 | 72 |
Days Payable | 92 | 132 | 84 | 102 | 111 | 91 |
Cash Conversion Cycle | 77 | 99 | 60 | 63 | 49 | 76 |
Working Capital Days | 80 | 73 | 74 | 87 | 72 | 97 |
ROCE % | 28% | 33% | 21% | 15% | 12% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
10h - Submission of Copy of newspaper advertisement dated 21 May 2025 pursuant to regulation 47 of SEBI LODR 2015
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
1d - Audio recording of Q4 and FY2025 earnings call available on company website.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
2d - Of Investor Presentation for Analysts/Institutional Investor Meeting to be held on May 20, 2025.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
2d - Innova Captab Q4 FY25 revenue ₹314.7Cr (+20%), PAT ₹29.6Cr (+3%); FY25 revenue ₹1243.7Cr (+15%), PAT ₹128.3Cr (+36%)
-
Shifting Of Registered Office
2d - Innova Captab shifts registered office within Navi Mumbai effective June 2, 2025.
Concalls
-
May 2025TranscriptNotesPPT
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT REC
-
Aug 2024Transcript PPT
-
Jun 2024Transcript PPT REC
-
May 2024TranscriptNotesPPT
-
Feb 2024Transcript PPT
Business Profile[1]
Innova Captab Limited is an integrated pharmaceutical player with a strong presence across the pharmaceutical value chain